Literature DB >> 11159999

Cure of Helicobacter pylori infection and resolution of gastritis by adoptive transfer of splenocytes in mice.

K A Eaton1, M E Mefford.   

Abstract

Vaccination suppresses Helicobacter pylori colonization but does not cure infection. Furthermore, postvaccination gastritis, likely induced by enhanced host response to residual colonization, may exacerbate disease. The goal of this study was to determine if adoptive transfer of C57BL/6 splenocytes to C57BL/6scid/scid (severe combined immunodeficient [SCID]) mice cures infection without exacerbating gastritis. H. pylori-infected and uninfected C57BL/6 mice and SCID recipients of normal splenocytes were killed at intervals between 5 and 51 weeks after infection. Colonization and gastritis were quantified, humoral immune responses were determined by enzyme-linked immunosorbent assay, and cellular immune responses were determined by delayed-type hypersensitivity response and by a proliferative response of cultured splenocytes to H. pylori sonicate. In infected C57BL/6 mice, gastritis developed gradually and bacterial colonization diminished but persisted throughout the experiment. In contrast, gastritis in infected recipient SCID mice developed rapidly and bacterial colonization decreased precipitously. Gastritis in those mice peaked 9 weeks after adoptive transfer, however, and began to resolve. By 45 weeks after transfer, gastritis had returned to background levels and bacteria were no longer detectable. Resolution of gastritis and elimination of infection were associated with a cellular but not humoral immune response to H. pylori antigens. These results demonstrate that although the host response fails to clear bacterial colonization in normal mice, enhanced cellular immune responses in recipient SCID mice are capable of clearing H. pylori infection and allowing resolution of gastritis. Thus, immune mechanisms of cure exist, and effective and safe vaccination protocols may be feasible.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11159999      PMCID: PMC97983          DOI: 10.1128/IAI.69.2.1025-1031.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Gastritis in urease-immunized mice after Helicobacter felis challenge may be due to residual bacteria.

Authors:  T H Ermak; R Ding; B Ekstein; J Hill; G A Myers; C K Lee; J Pappo; H K Kleanthous; T P Monath
Journal:  Gastroenterology       Date:  1997-10       Impact factor: 22.682

Review 2.  Therapeutic immunization against Helicobacter infection.

Authors:  A Lee
Journal:  Gastroenterology       Date:  1996-06       Impact factor: 22.682

3.  Local immune response in Helicobacter pylori-infected cats and identification of H. pylori in saliva, gastric fluid and faeces.

Authors:  J G Fox; S Perkins; L Yan; Z Shen; L Attardo; J Pappo
Journal:  Immunology       Date:  1996-07       Impact factor: 7.397

4.  Therapeutic immunization against Helicobacter mustelae in naturally infected ferrets.

Authors:  R Cuenca; T G Blanchard; S J Czinn; J G Nedrud; T P Monath; C K Lee; R W Redline
Journal:  Gastroenterology       Date:  1996-06       Impact factor: 22.682

Review 5.  Immune and inflammatory responses to Helicobacter pylori infection.

Authors:  J E Crabtree
Journal:  Scand J Gastroenterol Suppl       Date:  1996

6.  T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease.

Authors:  M M D'Elios; M Manghetti; M De Carli; F Costa; C T Baldari; D Burroni; J L Telford; S Romagnani; G Del Prete
Journal:  J Immunol       Date:  1997-01-15       Impact factor: 5.422

7.  Manifestations of the local gastric immune response in gnotobiotic piglets infected with Helicobacter pylori.

Authors:  S Krakowka; S S Ringler; K A Eaton; W B Green; R Leunk
Journal:  Vet Immunol Immunopathol       Date:  1996-07       Impact factor: 2.046

8.  Effect of oral immunization with recombinant urease on murine Helicobacter felis gastritis.

Authors:  J Pappo; W D Thomas; Z Kabok; N S Taylor; J C Murphy; J G Fox
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

9.  Identification of widespread Helicobacter hepaticus infection in feces in commercial mouse colonies by culture and PCR assay.

Authors:  B Shames; J G Fox; F Dewhirst; L Yan; Z Shen; N S Taylor
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

10.  Mucosal immune response to Helicobacter pylori and cytotoxic mechanism.

Authors:  T Sugiyama; T Yabana; A Yachi
Journal:  Scand J Gastroenterol Suppl       Date:  1995
View more
  18 in total

1.  Dendritic cell modification of neutrophil responses to infection after burn injury.

Authors:  Julia Bohannon; Weihua Cui; Edward Sherwood; Tracy Toliver-Kinsky
Journal:  J Immunol       Date:  2010-08-02       Impact factor: 5.422

2.  Age-dependent changes in susceptibility of suckling mice to individual strains of Helicobacter pylori.

Authors:  Hiroyuki Suto; Maojun Zhang; Douglas E Berg
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

3.  In vivo complementation of ureB restores the ability of Helicobacter pylori to colonize.

Authors:  Kathryn A Eaton; Joanne V Gilbert; Elizabeth A Joyce; Amy E Wanken; Tracy Thevenot; Patrick Baker; Andrew Plaut; Andrew Wright
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

4.  Immune evasion by Helicobacter pylori is mediated by induction of macrophage arginase II.

Authors:  Nuruddeen D Lewis; Mohammad Asim; Daniel P Barry; Thibaut de Sablet; Kshipra Singh; M Blanca Piazuelo; Alain P Gobert; Rupesh Chaturvedi; Keith T Wilson
Journal:  J Immunol       Date:  2011-02-04       Impact factor: 5.422

Review 5.  Helicobacter pylori interactions with host serum and extracellular matrix proteins: potential role in the infectious process.

Authors:  J Daniel Dubreuil; Giuseppe Del Giudice; Rino Rappuoli
Journal:  Microbiol Mol Biol Rev       Date:  2002-12       Impact factor: 11.056

Review 6.  Helicobacter pylori and gastric cancer: factors that modulate disease risk.

Authors:  Lydia E Wroblewski; Richard M Peek; Keith T Wilson
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

7.  Chronic Helicobacter pylori infection with Sydney strain 1 and a newly identified mouse-adapted strain (Sydney strain 2000) in C57BL/6 and BALB/c mice.

Authors:  Lucinda J Thompson; Stephen J Danon; John E Wilson; Jani L O'Rourke; Nina R Salama; Stanley Falkow; Hazel Mitchell; Adrian Lee
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

8.  Absence of CD4+CD25+ regulatory T cells is associated with a loss of regulation leading to increased pathology in Helicobacter pylori-infected mice.

Authors:  S Raghavan; M Fredriksson; A-M Svennerholm; J Holmgren; E Suri-Payer
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

9.  Systemic Th1 immunization of mice against Helicobacter pylori infection with CpG oligodeoxynucleotides as adjuvants does not protect from infection but enhances gastritis.

Authors:  Frank Sommer; Henning Wilken; Gerhard Faller; Michael Lohoff
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

10.  Complex T cell interactions contribute to Helicobacter pylori gastritis in mice.

Authors:  Brian M Gray; Clinton A Fontaine; Sara A Poe; Kathryn A Eaton
Journal:  Infect Immun       Date:  2012-12-21       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.